|
此文章由 12oz 原创或转贴,不代表本站立场和观点,版权归 oursteps.com.au 和作者 12oz 所有!转贴必须注明作者、出处和本声明,并保持内容完整
本帖最后由 12oz 于 2024-1-12 20:25 编辑
hgaox 发表于 2024-1-12 18:57
Despite his involvement in spurring their development via Operation Warp Speed, Trump largely down ...
不愿公开打疫苗就是反疫苗?就凭这个就得这个判断?请使用常理和逻辑。同一个wiki:
The U.S. government began the campaign under the presidency of Donald Trump with Operation Warp Speed, a public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January 20, 2021. Biden had an immediate goal of administering 100 million vaccine doses within his first hundred days in office, and signed an executive order which increased supplies for vaccination.[13][14][15] This goal was met on March 19, 2021.[16] On March 25, 2021, he announced he would increase the goal to 200 million within his first 100 days in office.[17] This goal was reached on April 21, 2021.[18]
还有这个wiki:
https://en.wikipedia.org/wiki/Operation_Warp_Speed
Operation Warp Speed (OWS) was a public–private partnership initiated by the United States government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.[1][2] The first news report of Operation Warp Speed was on April 29, 2020,[3][4][5] and the program was officially announced on May 15, 2020.[1] It was headed by Moncef Slaoui from May 2020 to January 2021 and by David A. Kessler from January to February 2021.[6] At the end of February 2021, Operation Warp Speed was transferred into the responsibilities of the White House COVID-19 Response Team.[7]
The program promoted mass production of multiple vaccines, and different types of vaccine technologies, based on preliminary evidence, allowing for faster distribution if clinical trials confirm one of the vaccines is safe and effective.[citation needed] The plan anticipated that some of these vaccines will not prove safe or effective, making the program more costly than typical vaccine development, but potentially leading to the availability of a viable vaccine several months earlier than typical timelines.[8] |
|